Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2012
09/20/2012CA2830254A1 Fc variants
09/20/2012CA2829968A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012CA2829963A1 Human tissue factor antibody and uses thereof
09/20/2012CA2828753A1 Antibodies to cd70
09/20/2012CA2828433A1 Diagnostic antibody assay
09/20/2012CA2828075A1 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
09/20/2012CA2828043A1 Overcoming resistance to erbb pathway inhibitors
09/20/2012CA2827188A1 Bi- and monospecific, asymmetric antibodies and methods of generating the same
09/19/2012EP2500440A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
09/19/2012EP2500438A2 Novel compositions and methods for the treatment of psoriasis
09/19/2012EP2500421A1 Glutathione S-transferase Omega 1 wild type specific antibody
09/19/2012EP2500420A1 Pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
09/19/2012EP2500416A1 Cell culture improvements
09/19/2012EP2500415A1 Cell culture improvements
09/19/2012EP2500414A1 Cell culture improvements
09/19/2012EP2500413A1 Cell culture improvements
09/19/2012EP2500362A2 Humanized antibodies against TL1A
09/19/2012EP2500361A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
09/19/2012EP2500360A2 Compositions and Methods for Diagnosing and Treating Cancer
09/19/2012EP2500359A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500358A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500357A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500356A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500355A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500354A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500353A2 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500352A1 Dual variable domain immunoglobulin and uses thereof
09/19/2012EP2500037A2 Use of TNF alpha inhibitor for treatment of erosive polyarthritis
09/19/2012EP2500035A1 Pharmaceutical formulation containing immunglobulin
09/19/2012EP2500034A1 Therapeutic agent for psoriasis or atopic dermatitis
09/19/2012EP2500030A2 Use of complement pathway inhibitors to treat ocular diseases
09/19/2012EP2499491A1 Immunoassay for assessing related analytes of different origin
09/19/2012EP2499256A1 Anti-c-mpl antibodies
09/19/2012EP2499163A1 Single-chain variable fragment (scfv) able to recognize and bind cd99 human protein
09/19/2012EP2499162A2 Material and methods for treating or preventing her-3 associated diseases
09/19/2012EP2499161A1 Antibodies specific for claudin 6 (cldn6)
09/19/2012EP2499160A1 Monoclonal antibodies against gmf-beta antigens, and uses therefor
09/19/2012EP2499159A2 Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
09/19/2012EP2499157A1 Anti-trypanosome therapeutic and diagnostic applications
09/19/2012EP2498809A1 Immune system modulating composition
09/19/2012CN1889979B IP-10 antibodies and their uses
09/19/2012CN1681529B Immunogenic compositions and diagnostic and therapeutic uses thereof
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102687019A Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium
09/19/2012CN102687010A Agents for treating disease
09/19/2012CN102686612A Conjugates targeting the CD163 receptor
09/19/2012CN102686611A Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
09/19/2012CN102686610A Anti notch-1 antibodies
09/19/2012CN102686609A Modified variable domain molecules and methods for producing and using same
09/19/2012CN102686608A Method for decreasing immunogenicity
09/19/2012CN102686239A Stable anti-TNFR1 polypeptides, antibody variable domains & antagonists
09/19/2012CN102680686A Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
09/19/2012CN102676675A Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
09/19/2012CN102676463A Enzyme associated with equol synthesis
09/19/2012CN102676462A Enzyme associated with equol synthesis
09/19/2012CN102676459A Monoclonal antibody resistant to thermostable direct hemolysin of vibrio parahaemolyticus and preparation method of monoclonal antibody
09/19/2012CN102675602A Biomimetic monolithic material with affine selectivity similar to that of protein A and preparation method and application thereof
09/19/2012CN102675463A Carbendazim monoclonal antibody, preparation method and application thereof
09/19/2012CN102675462A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/19/2012CN102675461A Monoclonal antibody to soluble lox-1
09/19/2012CN102675460A Anti-tumor necrosis factor alpha human-derived antibody
09/19/2012CN102675459A Preparation method of THP protein monoclonal antibody
09/19/2012CN102675458A Monoclonal antibodies and methods for their use in the detection of cervical disease
09/19/2012CN102675457A Preparation of peptidoglycan monoclonal antibody and products of peptidoglycan monoclonal antibod
09/19/2012CN102675437A Method for adjusting size of plant organs and inside asymmetry of floral organs
09/19/2012CN102671637A Biomimetic specific immune adsorption material with PAMAM (Polyamidoamine) as spacer arm, and preparation method and application thereof
09/19/2012CN101993856B Duck-origin coronavirus ZZ2004-resisting monoclonal antibody, hybridoma cell strain and application thereof
09/19/2012CN101886082B Method for producing humanized monoclonal antibody using animal mammary gland bioreactor
09/19/2012CN101568349B Methods of reducing phosphate absorption
09/19/2012CN101395473B Electrochemical detection method using water-soluble conjugates
09/19/2012CN101166763B Stabilized anti-hepatitis B (HBV) antibody formulations
09/18/2012USRE43672 Anti-IL-6 antibodies, compositions, methods and uses
09/18/2012US8268979 Human MutY
09/18/2012US8268976 Flea GABA receptor subunit nucleic acid molecules
09/18/2012US8268973 Anti-amyloid antibodies
09/18/2012US8268972 Humanized anti-C5aR antibodies
09/18/2012US8268971 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
09/18/2012US8268970 Human antibodies that bind mesothelin, and uses thereof
09/18/2012US8268969 Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
09/18/2012US8268966 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases
09/18/2012US8268964 MHC peptide complexes and uses thereof in infectious diseases
09/18/2012US8268773 Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist
09/18/2012US8268756 Mixture of binding proteins
09/18/2012US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
09/18/2012US8268592 Anti-system ASC amino acid transporter 2 (ASCT2) antibody
09/18/2012US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity
09/18/2012US8268587 Immunosuppressive polypeptides and nucleic acids
09/18/2012US8268582 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268318 Polyalkylene oxides having hindered ester-based biodegradable linkers
09/18/2012US8268313 Methods for using inhibitors of vascular endothelial growth factor activity
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012CA2769991A1 Met inhibitors for enhancing radiotherapy efficacy
09/18/2012CA2647086C Identification of a jak2 mutation in polycythemia vera
09/18/2012CA2603414C Anti-cd20 monoclonal antibody
09/18/2012CA2523449C Recombinant antibodies and fragments which recognize n glycolil gm3 ganglioside and its use in diagnosis and treatment of tumours
09/18/2012CA2514303C Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2445746C Chimeric immunoreceptor useful in treating human cancers
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1494